ପିତ୍ତକୋଷ କର୍କଟ

Evidence suggests distinct models of molecular and pathologic progression, and a growing body of genetics data points to a heterogeneous collection of underlying mutations in key oncogenes and tumor suppressor genes. Although tumor genetics have been used to tailor individual treatment regimens and guide clinical decision making in other cancers, these principles have not been applied in gallbladder malignancy. Recent clinical trials with targeted therapies seem promising, although the relationships between subsets of patients with positive responses to therapy and tumor genetics remain unexpl…

ପ୍ରାୟୋଜକ: Banaras Hindu University
ClinicalTrials.gov ରେ NCT05404347
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ 13 Aug 2024 · ଆମ ଦ୍ୱାରା 20 Oct 2026 ରେ ପଢ଼ାଯାଇଛି